Rhynchophylline as an agonist of sirtuin 3 ameliorates endothelial dysfunction via antagonizing mitochondrial damage of endothelial progenitor cells
British Journal of Pharmacology · 2025
DOI: 10.1111/bph.70032 ↗Kurz gefasst
Fachartikel in der Zeitschrift British Journal of Pharmacology, 2025. Verfasst von Lin Lin und 11 weiteren Autor:innen. Beteiligte Einrichtung: Innovative Institute of Chinese Medicine and Pharmacy, Shandong University of Traditional Chinese Medicine, Jinan, China. Hauptthemen laut MEDLINE: Sirtuin 3, Endothelial Progenitor Cells, Mitochondria, Oxindoles. Die Arbeit wurde bisher 49-mal zitiert (Crossref) und nennt 67 Literaturangaben. Gefördert von: NATCM's Project of High-level Construction of Key TCM Disciplines, National Natural Science Foundation of China, SKRD Program of Shandong Province.
Abstract (Originalsprache)
Background and Purpose Mitochondrial dysregulation of endothelial progenitor cells (EPCs) has been implicated in endothelial destruction and hypertension. Regulation of silent information regulator 3 (sirtuin 3; SIRT3) in mitochondrial damage of EPCs and the underlying molecular mechanisms remain unclear, and evidence of selective SIRT3 agonists for the treatment of hypertension also is lacking. Experimental Approach Here, we discovered a potent SIRT3 agonist, rhynchophylline (Rhy), and explored its underlying action on mitochondrial damage of EPCs and endothelial dysfunction. Key Results In spontaneously hypertensive rats, Rhy reduced blood pressure and ameliorated vasomotion, paralleling improved EPC function in the peripheral circulation. Moreover, Rhy alleviated mitochondrial damage and inhibited apoptosis via the mitochondrial apoptotic pathway. SIRT3 knockdown interrupted the regulation of mitochondrial homeostasis induced by Rhy, thus abolishing its antagonizing effect on EPC dysfunction and endothelial damage, suggesting that Rhy protection of EPC mitochondria is mediated via the activation of SIRT3. Rhy restrained the production of mitochondrial ROS and improved the activity of superoxide dismutase 2 (SOD2) in a SIRT3‐dependent manner, whereas silencing SOD2 eliminated the inhibition by Rhy of oxidative stress and apoptosis, reflecting that SOD2 was indispensable for the regulation of Rhy on mitochondrial dysfunction and the mitochondrial‐mediated apoptosis pathway. Conclusion and Implications SIRT3‐dependent mitochondrial homeostasis contributes to attenuating hypertension‐related EPC dysfunction and endothelial injury, and Rhy itself is a potent and targeted SIRT3 agonist that prevented mitochondrial dysfunction by regulating the SIRT3/SOD2 pathway, which may provide new clues for drug candidates for hypertension therapeutics.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Innovative Institute of Chinese Medicine and Pharmacy, Shandong University of Traditional Chinese Medicine, Jinan, China.
- First Clinical Medical College, Shandong University of Traditional Chinese Medicine, Jinan, China.
- Cardiovascular Department, Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Jinan, China.
- Experimental Center, Shandong University of Traditional Chinese Medicine, Jinan, China.
- College of Traditional Chinese Medicine, Shandong University of Traditional Chinese Medicine, Jinan, China.
ORCID-Profile: Yunlun Li
Förderung
- NATCM's Project of High-level Construction of Key TCM Disciplines
- National Natural Science Foundation of China
- SKRD Program of Shandong Province
- Natural Science Foundation of Shandong Province
- China Postdoctoral Science Foundation
- Outstanding Youth Innovation Team of Shandon Institutions of Higher Learning
- Jinan City School Integration Development Strategy Project
Zitieren
APA
Lin, L., Sun, B., Hu, Y., Yang, W., Li, J., Wang, D., Zhang, L., Lu, M., Li, Y., Li, Y., Zhang, D., & Li, C. (2025). Rhynchophylline as an agonist of sirtuin 3 ameliorates endothelial dysfunction via antagonizing mitochondrial damage of endothelial progenitor cells. British Journal of Pharmacology. https://doi.org/10.1111/bph.70032
Vancouver
Lin L, Sun B, Hu Y, Yang W, Li J, Wang D, et al. Rhynchophylline as an agonist of sirtuin 3 ameliorates endothelial dysfunction via antagonizing mitochondrial damage of endothelial progenitor cells. British Journal of Pharmacology. 2025. doi:10.1111/bph.70032
BibTeX
@article{Lin2025,
author = {Lin, Lin and Sun, Bowen and Hu, Yuanlong and Yang, Wenqing and Li, Jie and Wang, Danyang and Zhang, Lei and Lu, Mengkai and Li, Yuan and Li, Yunlun and Zhang, Dan and Li, Chao},
title = {Rhynchophylline as an agonist of sirtuin 3 ameliorates endothelial dysfunction via antagonizing mitochondrial damage of endothelial progenitor cells},
journal = {British Journal of Pharmacology},
year = {2025},
doi = {10.1111/bph.70032}
}
EUVIMED